Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Rhofade™ (oxymetazoline) – New Drug Approval
January 19, 2017 – Allergan announced the FDA approval of Rhofade (oxymetazoline) 1% cream, for the topical treatment of persistent facial erythema associated with rosacea in adults.
